Clinical Trial Update: Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer

View source ↗

Summary

A clinical trial evaluating whether epicardial adipose tissue can predict pulmonary embolism and death in patients with lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pulmonary Embolism

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Pulmonary Embolism, Lung Cancer | Status: WITHDRAWN